Endoskopie heute 2013; 26(4): 279-283
DOI: 10.1055/s-0033-1356323
© Georg Thieme Verlag KG Stuttgart · New York

DDW 2013: ERCP

DDW 2013: ERCP
R. Law
T. H. Baron
Weitere Informationen


02. Januar 2014 (online)


Die technische Entwicklung der ERCP hat ein Plateau erreicht. Dennoch waren bestimmte Gebiete im Bereich ERCP auf der diesjährigen „Digestive Disease Week (DDW)“ gut vertreten. Sie werden differenziert und detailliert diskutiert. Wie erwartet findet die Prävention der Post-ERCP-Pankreatitis (PEP) weiterhin Beachtung. Die Einlage von Pankreasgangstents scheint für den Endoskopiker unverändert die primäre Maßnahme zu bleiben, obwohl die pharmakologische Behandlung mit nichtsteroidalen Antirheumatika eine alternative oder komplementäre Therapie ist. Andere Themen waren der Einsatz der Cholangioskopie, die Diagnostik biliärer Strikturen, die Behandlung der Strikturen durch Stents und die Radiofrequenz-Ablation.


Technological advances in ERCP have appeared to plateau. Nonetheless, specific areas within ERCP were well represented at this year’s Digestive Disease Week (DDW). These areas are subdivided and discussed in detail. As expected, there remains concern about prevention of post-ERCP pancreatitis (PEP). Although pharmacologic therapy by using nonsteroidal anti-inflammatory drugs (NSAIDs) has clearly emerged as an alternative and/or adjunct to pancreatic duct (PD) stents, stents seem to remain the mainstay in the endoscopists’ armamentarium for the prevention of PEP. Other topics covered included the use of cholangioscopy, diagnosis of biliary strictures, and treatment of strictures by using stents and radiofrequency ablation.

  • Literatur

  • 1 Buxbaum JL, Yan AW, Yeh K et al. A prospective randomized trial of aggressive hydration to prevent post-ERCP pancreatitis. (abstract) Gastrointest Endosc 2013; 77: AB158
  • 2 Can early double guidewire technique facilitate common bile duct cannulation and reduce post ERCP pancreatitis? Results of a multicenter prospective randomized controlled trial: EDUCATION trial. (abstract) Gastrointest Endosc 2013; 77: AB183
  • 3 Lee TH, Park S, Choi HJ et al. Prospective sequential protocol analysis to facilitate selective biliary access for difficult biliary cannulation in ERCP. (abstract) Gastrointest Endosc 2013; 77: AB184
  • 4 Afghani E, Akshintala AV, Khashab M et al. 5 Fr pancreatic duct stents are superior to 3 Fr pancreatic duct stents for the prevention of post-ERCP pancreatitis in high-risk patients: a systematic review and network meta-analysis. (abstract) Gastrointest Endosc 2013; 77: AB159-AB160
  • 5 Kerdsirichairat T, Attam R, Arain MA et al. Urgent ERCP with pancreatic stent placement or replacement for salvage of post-ERCP pancreatitis. (abstract) Gastrointest Endosc 2013; 77: AB159
  • 6 Giovannini M, Caillol F, Bories E et al. Emid study: final results of a prospective bicentric study assessing probe-based confocal laser endomicroscopy (pCLE). Impact in the management of biliary strictures. (abstract) Gastrointest Endosc 2013; 77: AB126
  • 7 Shah RJ, Chennat JS, Cesaro P et al. Distinguishing benign from malignant dominant biliary strictures in patients with primary sclerosing cholangitis utilizing probe-based confocal laser endomicroscopy (pCLE): a multi-center, expert consensus review. (abstract) Gastrointest Endosc 2013; 77: AB164
  • 8 Lim P, Craig PI, Aggarwal V. The role of balloon-assisted cholangioscopy in a multi-ethnic cohort to assess complex biliary disease. (abstract) Gastrointest Endosc 2013; 77: AB125
  • 9 Farnik H, Weigt J, Malfertheiner P. Safety and success of direct retrograde cholangioscopy (DRC) by use of an ultraslim endoscope-results of a multicenter study. (abstract) Gastrointest Endosc 2013; 77: AB125-AB126
  • 10 Hayashi T, Kawakami H, Osanai M et al. A multicenter, prospective, randomized, controlled trial to determine the efficacy of endoscopic sphincterotomy prior to self-expandable metallic stent placement for unresectable pancreatic cancer patients: the Essence Trial in Hokkaido. (abstract) Gastrointest Endosc 2013; 77: AB1
  • 11 Cho JN, Han J, Kim HG et al. Prospective randomized trial comparing covered metal stent placed above and across the sphincter of Oddi in malignant biliary obstruction. Gastrointest Endosc 2013; 77: AB139-AB140
  • 12 Frozanpor F, Soderlund C, Linder S et al. Partially covered nitinol versus partially covered steel self-expandable metal stent in the palliative treatment of malignant distal biliary obstruction: final results from a prospective, randomized, multicenter trial. (abstract) Gastrointest Endosc 2013; 77: AB140
  • 13 Costamagna G, Reddy DN, Puspok A et al. Stent removability and mid-term stricture resolution after multi-month metal stenting of benign biliary strictures: interim report from an international prospective trial in 187 patients. (abstract), Gastrointest Endosc 2013; 77: AB164
  • 14 Kahaleh M, Sharaiha RZ, Widmer JL et al. Radiofrequency ablation of malignant biliary strictures: results of a collaborative registry. (abstract) Gastrointest Endosc 2013; 77: AB141
  • 15 Kallis Y, Phillips N, Steel A et al. Analysis of long-term outcomes after endoscopic radiofrequency ablation for bile duct strictures in pancreatic malignancy suggests potential survival benefit. (abstract) Gastrointest Endosc 2013; 77: AB165
  • 16 Strand DS, Cosgrove N, Patrie JT et al. ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma. (abstract) Gastrointest Endosc 2013; 77: AB140-AB141
  • 17 Kodali S, Klaus K, Ramesh J et al. ERCP perforations in the new millennium-results from 9000 ERCPs: a large tertiary referral center experience. (abstract) Gastrointest Endosc 2013; 77: AB294
  • 18 Artifon EL, Cunha MA, Aparicio DP et al. Surgical or endoscopic management of post-ERCP large duodenal perforations: a multicenter prospective trial. (abstract) Gastrointest Endosc 2013; 77: AB126-AB127